Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement

CONTEXT: Inhaled levosimendan may act as selective pulmonary vasodilator and avoid systemic side effects of intravenous levosimendan, which include decrease in systemic vascular resistance (SVR) and systemic hypotension, but with same beneficial effect on pulmonary artery pressure (PAP) and right ve...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Card Anaesth
Huvudupphovsmän: Kundra, Tanveer Singh, Nagaraja, P S, Bharathi, K S, Kaur, Parminder, Manjunatha, N
Materialtyp: Artigo
Språk:Inglês
Publicerad: Medknow Publications & Media Pvt Ltd 2018
Ämnen:
Original Article: Janak Mehta Award
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078018/
https://ncbi.nlm.nih.gov/pubmed/30052230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aca.ACA_19_18
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk